p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5α

Journal of Virology

Volumn 84, Issue 12, 2010, Pages 5997-6006

  O'Connor, Christopher ^b   Pertel, Thomas ^a   Gray, Seth ^b   Robia, Seth L ^b   Bakowska, Joanna C ^b   Luban, Jeremy ^a   Campbell, Edward M ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; INTERFERON; PROTEIN P62; SMALL INTERFERING RNA; TRIPARTITE MOTIF PROTEIN 5;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROVIRUS; RHESUS MONKEY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARRIER PROTEINS; CELL LINE; HIV INFECTIONS; HIV-1; HUMANS; PROTEIN BINDING; RETROVIRIDAE; RETROVIRIDAE INFECTIONS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; MIRIDAE;

EID: 77952694865     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02412-09     Document Type: Article

References (47)

1. Anderson, J. L., E. M. Campbell, X. Wu, N. Vandegraaff, A. Engelman, and T. J. Hope. 2006. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. J. Virol. 80:9754-9760.
2. Ang, E., N. J. Pavlos, S. L. Rea, M. Qi, T. Chai, J. P. Walsh, T. Ratajczak, M. H. Zheng, and J. Xu. 2009. Proteasome inhibitors impair RANKL-induced NF-kappaB activity in osteoclast-like cells via disruption of p62, TRAF6, CYLD, and IkappaBalpha signaling cascades. J. Cell. Physiol. 220: 450-459.
3. Asaoka, K., K. Ikeda, T. Hishinuma, K. Horie-Inoue, S. Takeda, and S. Inoue. 2005. A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. Biochem. Biophys. Res. Commun. 338:1950-1956.
4. Barr, S. D., J. R. Smiley, and F. D. Bushman. 2008. The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog. 4:e1000007.
5. Bossuyt, J., S. Despa, F. Han, Z. Hou, S. L. Robia, J. B. Lingrel, and D. M. Bers. 2009. Isoform specificity of the Na/K-ATPase association and regulation by phospholemman. J. Biol. Chem. 284:26749-26757.
6. Campbell, E. M., M. P. Dodding, M. W. Yap, X. Wu, S. Gallois-Montbrun, M. H. Malim, J. P. Stoye, and T. J. Hope. 2007. TRIM5 alpha cytoplasmic bodies are highly dynamic structures. Mol. Biol. Cell 18:2102-2111.
7. Campbell, E. M., R. Nunez, and T. J. Hope. 2004. Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J. Virol. 78:5745-5755.
8. Campbell, E. M., O. Perez, J. L. Anderson, and T. J. Hope. 2008. Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha. J. Cell Biol. 180:549-561.
9. Carthagena, L., A. Bergamaschi, J. M. Luna, A. David, P. D. Uchil, F. Margottin-Goguet, W. Mothes, U. Hazan, C. Transy, G. Pancino, and S. Nisole. 2009. Human TRIM gene expression in response to interferons. PLoS One 4:e4894.
10. Carthagena, L., M. C. Parise, M. Ringeard, M. K. Chelbi-Alix, U. Hazan, and S. Nisole. 2008. Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities. Retrovirology 5:59.
11. Deng, L., C. Wang, E. Spencer, L. Yang, A. Braun, J. You, C. Slaughter, C. Pickart, and Z. J. Chen. 2000. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103:351-361.
12. Diaz-Griffero, F., A. Kar, M. Perron, S.-H. Xiang, H. Javanbakht, X. Li, and J. Sodroski. 2007. Modulation of retroviral restriction and proteasome inhibitor- resistant turnover by changes in the TRIM5α B-box 2 domain. J. Virol. 81:10362-10378. (Pubitemid 47463311)
13. Diaz-Griffero, F., X. Li, H. Javanbakht, B. Song, S. Welikala, M. Stremlau, and J. Sodroski. 2006. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 349:300-315. (Pubitemid 43796239)
14. Eldin, P., L. Papon, A. Oteiza, E. Brocchi, T. G. Lawson, and N. Mechti. 2009. TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus. J. Gen. Virol. 90:536-545.
15. Gack, M. U., Y. C. Shin, C. H. Joo, T. Urano, C. Liang, L. Sun, O. Takeuchi, S. Akira, Z. Chen, S. Inoue, and J. U. Jung. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920.
16. Gao, B., Z. Duan, W. Xu, and S. Xiong. 2009. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology 50:424-433.
17. Geetha, T., M. L. Seibenhener, L. Chen, K. Madura, and M. W. Wooten. 2008. p62 serves as a shuttling factor for TrkA interaction with the proteasome. Biochem. Biophys. Res. Commun. 374:33-37.
18. Hatziioannou, T., D. Perez-Caballero, A. Yang, S. Cowan, and P. D. Bieniasz. 2004. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc. Natl. Acad. Sci. U. S. A. 101:10774-10779.
19. Huthoff, H., and G. J. Towers. 2008. Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha. Trends Microbiol. 16:612-619.
20. Kawai, K., A. Saito, T. Sudo, and H. Osada. 2008. Specific regulation of cytokine-dependent p38 MAP kinase activation by p62/SQSTM1. J. Biochem. 143:765-772. (Pubitemid 351918937)
21. Keckesova, Z., L. M. Ylinen, and G. J. Towers. 2004. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc. Natl. Acad. Sci. U. S. A. 101:10780-10785.
22. Kelly, E. M., Z. Hou, J. Bossuyt, D. M. Bers, and S. L. Robia. 2008. Phospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells. J. Biol. Chem. 283:12202-12211.
23. Kenworthy, A. K. 2001. Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy. Methods 24:289-296. (Pubitemid 32846434)
24. Kim, J. Y., and K. Ozato. 2009. The sequestosome 1/p62 attenuates cytokine gene expression in activated macrophages by inhibiting IFN regulatory factor 8 and TNF receptor-associated factor 6/NF-kappaB activity. J. Immunol. 182:2131-2140.
25. Li, M., L. G. Reddy, R. Bennett, N. D. Silva, Jr., L. R. Jones, and D. D. Thomas. 1999. A fluorescence energy transfer method for analyzing protein oligomeric structure: application to phospholamban. Biophys. J. 76:2587-2599. (Pubitemid 29264618)
26. Moscat, J., M. T. Diaz-Meco, A. Albert, and S. Campuzano. 2006. Cell signaling and function organized by PB1 domain interactions. Mol. Cell 23:631-640. (Pubitemid 44292560)
27. Moscat, J., M. T. Diaz-Meco, and M. W. Wooten. 2007. Signal integration and diversification through the p62 scaffold protein. Trends Biochem. Sci. 32:95-100.
28. Ozato, K., D. M. Shin, T. H. Chang, and H. C. Morse III. 2008. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8:849-860.
29. Pankiv, S., T. H. Clausen, T. Lamark, A. Brech, J. A. Bruun, H. Outzen, A. Overvatn, G. Bjorkoy, and T. Johansen. 2007. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282:24131-24145.
30. Perron, M. J., M. Stremlau, B. Song, W. Ulm, R. C. Mulligan, and J. Sodroski. 2004. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc. Natl. Acad. Sci. U. S. A. 101: 11827-11832.
31. Reymond, A., G. Meroni, A. Fantozzi, G. Merla, S. Cairo, L. Luzi, D. Riganelli, E. Zanaria, S. Messali, S. Cainarca, A. Guffanti, S. Minucci, P. G. Pelicci, and A. Ballabio. 2001. The tripartite motif family identifies cell compartments. EMBO J. 20:2140-2151. (Pubitemid 32410584)
32. Rizzo, M. A., G. Springer, K. Segawa, W. R. Zipfel, and D. W. Piston. 2006. Optimization of pairings and detection conditions for measurement of FRET between cyan and yellow fluorescent proteins. Microsc. Microanal. 12:238-254.
33. Rold, C. J., and C. Aiken. 2008. Proteasomal degradation of TRIM5alpha during retrovirus restriction. PLoS Pathog. 4:e1000074.
34. Sakuma, R., A. A. Mael, and Y. Ikeda. 2007. Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells. J. Virol. 81:10201-10206. (Pubitemid 350067723)
35. Sebastian, S., and J. Luban. 2007. The retroviral restriction factor TRIM5alpha. Curr. Infect. Dis. Rep. 9:167-173.
36. Seibenhener, M. L., J. R. Babu, T. Geetha, H. C. Wong, N. R. Krishna, and M. W. Wooten. 2004. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol. Cell. Biol. 24: 8055-8068.
37. Seibenhener, M. L., T. Geetha, and M. W. Wooten. 2007. Sequestosome 1/p62 - more than just a scaffold. FEBS Lett. 581:175-179. (Pubitemid 46096472)
38. Shi, M., W. Deng, E. Bi, K. Mao, Y. Ji, G. Lin, X. Wu, Z. Tao, Z. Li, X. Cai, S. Sun, C. Xiang, and B. Sun. 2008. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 9:369-377.
39. Song, B., H. Javanbakht, M. Perron, D. H. Park, M. Stremlau, and J. Sodroski. 2005. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. J. Virol. 79:3930-3937. (Pubitemid 40388333)
40. Stremlau, M., C. M. Owens, M. J. Perron, M. Kiessling, P. Autissier, and J. Sodroski. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853. (Pubitemid 38297747)
41. Sudo, T., M. Maruyama, and H. Osada. 2000. p62 functions as a p38 MAP kinase regulator. Biochem. Biophys. Res. Commun. 269:521-525.
42. Uchil, P. D., B. D. Quinlan, W. T. Chan, J. M. Luna, and W. Mothes. 2008. TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog. 4:e16.
43. Wolf, D., and S. P. Goff. 2007. TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 131:46-57. (Pubitemid 47498526)
44. Wooten, M. W., T. Geetha, J. R. Babu, M. L. Seibenhener, J. Peng, N. Cox, M. T. Diaz-Meco, and J. Moscat. 2008. Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins. J. Biol. Chem. 283:6783-6789.
45. Wooten, M. W., T. Geetha, M. L. Seibenhener, J. R. Babu, M. T. Diaz-Meco, and J. Moscat. 2005. The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination. J. Biol. Chem. 280:35625-35629.
46. Wu, X., J. L. Anderson, E. M. Campbell, A. M. Joseph, and T. J. Hope. 2006. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proc. Natl. Acad. Sci. U. S. A. 103:7465-7470.
47. Yamauchi, K., K. Wada, K. Tanji, M. Tanaka, and T. Kamitani. 2008. Ubiquitination of E3 ubiquitin ligase TRIM5 alpha and its potential role. FEBS J. 275:1540-1555. (Pubitemid 351388800)